Research & Development
Formulation R&D and novel drug-delivery systems.
Research-driven formulations for patients in 60 countries.
350+
Approved molecules
350+
Approved molecules
60
Countries supplied
4
WHO-GMP plants
8%
Revenue into R&D
About Us
Medivance Pharma develops and manufactures high-quality generic and specialty medicines. Our WHO-GMP plants, dedicated R&D centre and global regulatory team bring affordable therapies to patients across 60 countries.
Affordable, high-quality medicines for every patient.
A research-led global pharmaceutical leader.
Quality, ethics and patient-first innovation.
Services
Everything you need, delivered by people who know the work inside out.
Formulation R&D and novel drug-delivery systems.
Tablets, capsules, syrups and injectables.
High-purity APIs in USFDA-approved plants.
Stability, microbiology and analytical testing.
Third-party and loan-licence production.
Dossiers for USFDA, EU-GMP and WHO markets.
How It Works
Molecule selection and formulation design.
Bioequivalence and clinical studies.
Regulatory filings across global markets.
GMP manufacturing and cold-chain distribution.
Testimonials
“A contract partner that treats our quality standards as their own.”
Dr. Mark Ellis
Supply Director, EU
“Dossier to approval in record time — their regulatory team is outstanding.”
Dr. Kavita Rao
Pharma Distributor
“Reliable supply through the toughest disruptions. That is true partnership.”
Hemant Joshi
Hospital Chain Procurement
Pricing
MOQ 50k units
Talk to our team today — we usually reply within the hour.
Contact
Have a question or ready to book? Send us a message and we'll get back to you shortly.